文献速递中医妇科针灸推拿

艾灸通过调控线粒体生物合成与改善卵母细胞质量延缓卵巢衰老

Moxibustion delays ovarian aging by regulating mitochondrial biogenesis and improving oocyte quality.
PubMed 文献 · Chin Med · 2026-04-10

该研究以2至14月龄小鼠为对象,检测卵巢功能以确定生殖衰老年龄及艾灸干预最佳时机,并评估卵母细胞质量与线粒体功能。结果显示10月龄小鼠出现卵巢功能衰退,艾灸可显著提高激素水平、增加生长卵泡数量、提升胚胎着床率与活产率、降低胚胎死亡率,效果在10月龄小鼠最明显;其机制可能与增加线粒体数量、改善线粒体质量及影响线粒体生物合成有关,且部分效应可被PGC-1α抑制剂减弱。

要点

  • 10月龄小鼠出现年龄相关卵巢功能减退,为艾灸干预延缓衰老的适宜观察时点。
  • 艾灸可改善衰老小鼠激素水平、生长卵泡数、胚胎着床与活产率并降低胚胎死亡率。
  • 艾灸益处与改善卵母细胞质量及促进线粒体生物合成相关,部分依赖PGC-1α通路。

核心结论

  • 艾灸作为非药物干预可能延缓卵巢衰老,并可能成为延长人类生育力的治疗策略。

研究设计与样本

  • 研究对2至14月龄小鼠进行卵巢功能检测,以确定生殖衰老年龄及艾灸干预延缓衰老的最佳时机。

主要发现

  • 10月龄小鼠表现出与衰老相关的卵巢功能障碍。
  • 艾灸显著升高衰老小鼠激素水平、增加生长卵泡数量、提高胚胎着床率与活产率并降低胚胎死亡率,效果在10月龄小鼠最明显。
  • 艾灸增加线粒体数量、改善线粒体质量并影响线粒体生物合成,效果与PGC-1α激动剂丙戊酸相当。
  • 艾灸的有益效应可被PGC-1α抑制剂部分减弱。

临床怎么用

  • 对年龄相关卵巢功能减退人群,可将艾灸作为非药物辅助策略考虑,但需结合个体情况与临床评估。

局限性

  • 研究为小鼠实验,人类临床应用需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The growing trend of delayed childbearing in contemporary society has made fertility preservation a significant issue, prompting the search for diverse therapeutic options. Conversely, moxibustion is gaining increasing attention as a potential non-pharmacological therapy for supporting reproductive health. METHODS: Mice aged 2 to 14 months were assessed for ovarian function detection to determine the age of reproductive senescence and to identify the optimal time for moxibustion intervention to delay senescence. Oocyte quality and mitochondrial function assessments were conducted to investigate the role of mitochondrial biogenesis in ovarian aging and the underlying mechanisms following moxibustion intervention. RESULTS: Mice aged 10 months demonstrated ovarian dysfunction associated with aging. Moxibustion significantly elevated hormone levels, increased the number of growing follicles, enhanced embryo implantation and viable birth rates, and reduced embryonic mortality in aging mice. The most pronounced effects were observed in 10-month-old mice. These beneficial outcomes might be linked to improved oocyte quality. Crucially, moxibustion positively increased mitochondrial quantity, enhanced mitochondrial quality, and influenced mitochondrial biogenesis, an effect comparable to that of the peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) agonist valproic acid. Furthermore, the beneficial effects of moxibustion were partially attenuated by a PGC-1α inhibitor. CONCLUSIONS: Moxibustion, as a non-pharmacological intervention, may mitigate ovarian aging and serve as an effective therapeutic strategy for extending human fertility.

来源:Chin Med,查看原文。版权归原作者所有。

引用

  1. Yin Y, Xu Y, Li Z, et al. Moxibustion delays ovarian aging by regulating mitochondrial biogenesis and improving oocyte quality. Chin Med. 2026. PMID: 41957658. doi:10.1186/s13020-026-01375-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。